
Smoking cessation in HIV care: effectiveness and cost-effectiveness evidence
From the abstract: “Most evidence originated from high-income countries, with three randomized controlled trials conducted in LMICs (Kenya, South Africa and Vietnam).”

From the abstract: “Most evidence originated from high-income countries, with three randomized controlled trials conducted in LMICs (Kenya, South Africa and Vietnam).”

From the abstract: “This study aimed to evaluate drug use patterns at Thika Level 5 Hospital in Kenya using World Health Organization (WHO) core drug use indicators.”

From the abstract: “This qualitative study was nested within the SEARCH Sapphire pilot randomised controlled trial testing hypertension treatment through CHW-facilitated, clinician-driven telehealth (intervention) compared to clinic-based care (control) for adults aged ≥40 years with moderate-severe hypertension in rural western Kenya and southwestern Uganda.”

From the abstract: “This study investigates the co-occurrence and spatial distribution of antibiotic residues and ARGs in livestock manure and agricultural soils from Machakos, Kiambu, and Kajiado counties in Kenya, regions characterized by intensive livestock farming.”

From the abstract: “Secondary data comprising 14,439 men aged 15–54 years from the 2022 cross-sectional Demographic and Health Survey (KDHS) in Kenya were analyzed using univariable and multivariable logistic regression analyses in SPSS, version 29.”

From the abstract: “Unsupervised clustering identified participants with elevated SARS-CoV-2 seroreactivity relative to pre-pandemic samples.”

From the abstract: “To elucidate women’s lived experiences with side effect counseling and management, we examined how women in Kenya and Ethiopia manage contraceptive side effects with and without help from healthcare providers, and what their preferences are for support.”

From the abstract: “A longitudinal cohort of 1003 FSWs (257 living with HIV) from Nairobi, Kenya was enrolled in mid-2019, just prior to the pandemic, and plasma was available for SARS-CoV-2 serology from 827 participants at clinical follow up approximately one year later.”

From the abstract: “We conducted observations in clinics and in-depth interviews with HCWs from January 2023 to January 2024 at Tanzanian intervention sites within the East Africa Point-of-Care Viral Load Monitoring (EAPOC-VL) study.”

From the abstract: “Data collected included dispensing source (over-the-counter [OTC] versus prescription), clinical indication, antibiotics dispensed, course completion, and self-reported repeat antibiotic use within the preceding month.”